Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Vaccine|November 11, 2008
Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responsesAndreas Bråve, David Hallengärd, Maria Malm, et al.
Viral Immunology|December 20, 2005
Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGHMaria Malm, Erik Rollman, Mart Ustav, et al.
Frontiers in Cellular and Infection Microbiology|July 10, 2023
SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusionVili Lampinen, Stina Gröhn, Saana Soppela, et al.
Immunology|November 3, 2011
A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particlesKirsi Tamminen, Leena Huhti, Tiia Koho, et al.
Virology|December 11, 2021
Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technologySuvi Heinimäki, Vili Lampinen, Kirsi Tamminen, et al.
AIDS Research and Human Retroviruses|July 13, 2006
Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccineVesna Blazevic, Andres Männik, Maria Malm, et al.
Vaccine|January 22, 2022
Safety and immunogenicity studies in animal models support clinical development of a bivalent norovirus-like particle vaccine produced in plantsDaniel Tusé, Maria Malm, Kirsi Tamminen, et al.
The Journal of Infectious Diseases|March 19, 2011
Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young childrenLeena Huhti, Evelin D Szakal, Leena Puustinen, et al.
Journal of Nanobiotechnology|January 20, 2021
Modular vaccine platform based on the norovirus-like particleVili Lampinen, Suvi Heinimäki, Olli H Laitinen, et al.
Archives of Virology|May 29, 2015
Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccineSuvi Lappalainen, Ana Ruth Pastor, Maria Malm, et al.
Pageof 6